1501 - 1510 of 7939 Results
Title
Year
-
OPENTitle: What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 61End Page: 67Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200786Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/61.full.pdfCitation Count: 14
-
RESTRICTEDTitle: Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.971252Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.971252/pdfCitation Count: 8
-
OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 8
- Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases2022OPENTitle: Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body DiseasesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2086End Page: 2098Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29171Best OA location URL: https://doi.org/10.1002/mds.29171Citation Count: 11
-
OPENTitle: A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000200008Best OA location URL: https://ng.neurology.org/content/nng/8/5/e200008.full.pdfCitation Count: 6
-
OPENTitle: Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 2Start Page: 507End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac294Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169283Citation Count: 7
-
OPENTitle: Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule bindingJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 479Issue #: 17Start Page: 1759End Page: 1783Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bcj20220161Best OA location URL: https://portlandpress.com/biochemj/article-pdf/479/17/1759/936843/bcj-2022-0161.pdfCitation Count: 73
-
RESTRICTEDTitle: Longitudinal Mediating Effect of Depression on the Relationship between Excessive Daytime Sleepiness and Activities of Daily Living in Parkinson’s DiseaseJournal Name: Clinical GerontologistPublisher: Informa UK LimitedVol: 47Issue #: 3Start Page: 426End Page: 435Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/07317115.2022.2111014Citation Count: 4
-
RESTRICTEDTitle: Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approachesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.979826Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.979826/pdfCitation Count: 8
- Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last Decade2022RESTRICTEDTitle: Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last DecadeJournal Name: GenesPublisher: MDPI AGVol: 13Issue #: 8Start Page: 1426End Page: 1426Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes13081426Best OA location URL: https://www.mdpi.com/2073-4425/13/8/1426/pdf?version=1660204965Citation Count: 5